Alto Ingredients
Alto Ingredients' revenue fell 4.9% to $918 million in fiscal 2025. Its operating margin was 0.8%, up from −5.3% a year earlier. Free cash flow was $9 million. The diluted share count rose 3.0%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Alto Ingredients does
Alto Ingredients makes and sells specialty alcohols, fuel ethanol and food and feed ingredients in the United States. It runs five alcohol plants: three in Illinois, one in Oregon and one in Idaho. Its alcohols go into mouthwash, cosmetics, pharmaceuticals, cleaners, alcoholic drinks, paints and fuel. Its ingredient products include dried yeast, corn protein, distillers grains and carbon dioxide, used in animal feed, pet food and food.
The company reports three segments. Pekin production covers the three Illinois plants. Western production covers the Oregon and Idaho plants, including a carbon dioxide plant. Marketing and distribution sells the company's own alcohols and ethanol that other producers make. Its results depend heavily on the prices of corn and natural gas, which it buys, compared with the prices of the alcohols and ingredients it sells. Specialty alcohols for industry and agriculture, food and beverage, and health, home and beauty made up about 11%, 6% and 2% of 2025 sales to customers in those three markets.
The company has about 390 full-time employees. It says it can make 330 million gallons of alcohol a year.
Its biggest risks, as it describes them
- Swings in the prices of corn and natural gas versus the prices of its alcohols and ingredients, which can push sales below the cost of production.
- Having to idle or stop plants when market conditions are poor, as it did at its Magic Valley plant.
- Customers that may pay late, not pay, or seek new prices even under longer-term contracts.
Income statement
From fiscal 2021 to 2025, earnings per share fell 28.4% a year and net income 26.7% a year, as new shares raised the share count by 5% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 51 | 36 | 30 | 36 | 23 |
| Debt incl. finance leases | 50 | 78 | 91 | 100 | 85 |
| Net debt (negative means net cash) | −0 | 42 | 61 | 64 | 61 |
| Net debt to EBITDA | −0.0x | — | — | — | 1.9x |
| Debt to equity | 0.1x | 0.2x | 0.3x | 0.4x | 0.3x |
| Interest coverage | 11.2x | −33.6x | −3.2x | −6.8x | 0.7x |
| Current ratio | 3.3x | 2.5x | 2.6x | 2.6x | 2.6x |
| Quick ratio | 2.5x | 1.7x | 1.8x | 1.8x | 1.6x |
Cash flow
Projections
Project Alto Ingredients' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What Alto Ingredients says to expect
- Full year 2026: Section 45Z tax credits
Through our efforts to lower our carbon scores at our Columbia facility and Pekin dry mill, we now expect to generate a minimum of $20 million, net of monetization costs, in 2026.
Insider trades
Over the 12 months between November 14, 2025 and November 13, 2026, 1 insider bought $361,250 of Alto Ingredients shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Gilbert E NathanDirector | Bought | 10,000 | $3.93 | $39,300 | Form 4 |
| Aug 11, 2026 | Gilbert E NathanDirector | Bought | 50,000 | $4.15 | $207,500 | Form 4 |
| May 13, 2026 | Gilbert E NathanDirector | Bought | 5,000 | $4.45 | $22,250 | Form 4 |
| May 12, 2026 | Gilbert E NathanDirector | Bought | 20,000 | $4.61 | $92,200 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 5 of 9 | 2 of 9 | 6 of 9 |
| Rule of 40 | −9.1% | −22.6% | −4.0% |
| Altman Z'' | −2.66 | −4.66 | −3.25 |
| Accruals ratio | −10.7% | −13.0% | 0.0% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Pass |
| Cash from operations is positive | Pass | Fail | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | Fail | Fail | Pass |
| Current ratio rose | Pass | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | 5 of 9 | 2 of 9 | 6 of 9 |
Compare
Put Alto Ingredients side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Alto Ingredients | FY25 | −4.9% | 0.8% | 0.9% | 2.5% | 1.9x | 6 | |
| Balchem | FY25 | 8.8% | 20.2% | 16.7% | — | — | — | Compare |
| Ecovyst | FY25 | 20.9% | 9.0% | 9.7% | 2.9% | 1.4x | 6 | Compare |
| Ingevity | FY25 | −2.7% | 35.9% | 23.4% | 24.6% | 2.1x | 6 | Compare |
| Perimeter Solutions | FY25 | 16.4% | −30.8% | 31.9% | −10.2% | — | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,625 | 1,632 | 1,515 | 1,425 | 897 | 1,208 | 1,336 | 1,223 | 965 | 918 |
| Revenue growth | 35.8% | 0.5% | −7.2% | −6.0% | −37.0% | 34.7% | 10.6% | −8.4% | −21.1% | −4.9% |
| Gross profit | 54 | 6 | −15 | −10 | 53 | 68 | −28 | 16 | 10 | 35 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 24 | −26 | −52 | −75 | 10 | 40 | −61 | −24 | −52 | 7 |
| Net income | 1 | −35 | −60 | −89 | −15 | 46 | −42 | −28 | −59 | 13 |
| Diluted EPS (US$) | 0.00 | −0.85 | −1.42 | −1.90 | −0.28 | 0.61 | −0.60 | −0.40 | −0.82 | 0.16 |
| Diluted shares (millions) | 42 | 43 | 43 | 47 | 59 | 72 | 72 | 73 | 74 | 76 |
| Cash flow | ||||||||||
| Cash from operations | 37 | 36 | 2 | −31 | 72 | 27 | 6 | 22 | −4 | 13 |
| Capital expenditure | 19 | 21 | 15 | 3 | 7 | 16 | 38 | 30 | 11 | 5 |
| Free cash flow | 18 | 16 | −14 | −35 | 65 | 10 | −32 | −8 | −15 | 9 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 0 | 0 |
| Acquisitions | 0 | 30 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 7 |
| Stock-based compensation | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 64 | 50 | 27 | 19 | 48 | 51 | 36 | 30 | 36 | 23 |
| Debt incl. finance leases | — | 244 | 234 | 246 | 98 | 50 | 78 | 91 | 100 | 85 |
| Total assets | 708 | 720 | 660 | 612 | 477 | 485 | 478 | 454 | 401 | 389 |
| Total liabilities | 290 | 337 | 341 | 385 | 181 | 140 | 170 | 175 | 176 | 144 |
| Shareholders' equity | 388 | 356 | 319 | 227 | 296 | 345 | 308 | 280 | 225 | 245 |
| Margins and ratios | ||||||||||
| Gross margin | 3.4% | 0.4% | −1.0% | −0.7% | 5.9% | 5.6% | −2.1% | 1.3% | 1.0% | 3.8% |
| Operating margin | 1.4% | −1.6% | −3.4% | −5.2% | 1.1% | 3.3% | −4.6% | −1.9% | −5.3% | 0.8% |
| Net margin | 0.1% | −2.1% | −4.0% | −6.2% | −1.7% | 3.8% | −3.1% | −2.3% | −6.1% | 1.4% |
| Free cash flow margin | 1.1% | 1.0% | −0.9% | −2.4% | 7.3% | 0.9% | −2.4% | −0.6% | −1.5% | 0.9% |
| Rule of 40 (growth + FCF margin) | 36.9% | 1.4% | −8.1% | −8.4% | −29.8% | 35.5% | 8.2% | −9.1% | −22.6% | −4.0% |
| Return on capital | — | — | −7.4% | −12.0% | 1.9% | 11.2% | −14.0% | −5.5% | −13.0% | 2.5% |
| Return on equity | 0.4% | −9.4% | −17.8% | −32.6% | −5.8% | 14.4% | −12.7% | −9.5% | −23.4% | 5.7% |
| Return on assets | 0.2% | −4.9% | −8.7% | −14.0% | −2.8% | 9.6% | −8.6% | −6.0% | −13.8% | 3.4% |
| Net debt to EBITDA | — | 14.9x | — | — | 1.2x | −0.0x | — | — | — | 1.9x |